FDA Announces Upcoming Meeting to Discuss GRAIL Inc.'s Galleri® Test Premarket Approval Application.

The U.S. Food and Drug Administration (FDA) is holding a meeting on September 23 of the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee. The committee will discuss, make recommendations, and vote on information regarding GRAIL Inc.'s premarket approval application for its Galleri® test.